In pancreatic cancer cells, METTL14 directly targets the downstream mRNA of PERP, increasing its turnover and decreasing both mRNA and protein levels of PERP, which promotes cancer cell proliferation and metastasis (Wang et al., 2020). Here, PERP is linked to pancreatic neoplasm.